[Diabetes mellitus and obesity: monotherapy using biguanides].
D000328:Adult; D001645:Biguanides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D002648:Child; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000628:therapy; D003967:Diarrhea / Q000139:chemically induced; D004035:Diet Therapy; D005414:Flatulence / Q000139:chemically induced; D006801:Humans; D007328:Insulin / Q000097:blood; D009325:Nausea / Q000139:chemically induced; D009765:Obesity; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use
D001645:Biguanides; D007328:Insulin; D013453:Sulfonylurea Compounds
Diabetes mellitus und Adipositas: Monotherapie mit Biguaniden.